Results 71 to 80 of about 22,818 (176)

Breakthrough serogroup Y meningococcal disease in a vaccinated patient with myasthenia gravis receiving ravulizumab: a case report

BMC Infectious Diseases
We report a case of fulminant invasive meningococcal disease caused by Neisseria meningitidis serogroup Y in a young, immunocompromised adult with myasthenia gravis receiving long-term immunosuppressive therapy including ravulizumab, despite prior ...
Silvija Šoprek Strugar, Paško Petrović, Iva Butić, Branimir Gjurašin, Marko Kutleša   +4 more
doaj   +1 more source

A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections.

PLoS ONE
The genus Neisseria includes two major human pathogens: N. meningitidis causing bacterial meningitis/septicemia and N. gonorrhoeae causing gonorrhoea.
Soeren Metelmann, Alexander Thompson, Anna Donten, Segun Oke, Suzy Sun, Ray Borrow, Feng Xu, Roberto Vivancos, Valerie Decraene, Lorenzo Pellis, Ian Hall   +10 more
doaj   +1 more source

Meningoccocal meningitis complicated with subdural effusion: a report of two infant cases

Journal of Infection in Developing Countries, 2007
Neisseria meningitidis is a major cause of invasive bacterial infection in children of all ages. Children less than 1 year of age are at greater risk of invasive disease than older children. In endemic countries, the invasive meningococcal infections are
Victor Perez-Pico,1 Eduardo Llausas-Magana,1 Angel Leon-Ramirez,1 Giordano Perez-Gaxiola,2 and Nidia Leon-Sicairos.3
doaj  

Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections. [PDF]

Virulence, 2019
Muenstermann M, Strobel L, Klos A, Wetsel RA, Woodruff TM, Köhl J, Johswich KO.   +6 more
europepmc   +1 more source

The chemoprophylaxis of meningococcal infection [PDF]

Journal of Antimicrobial Chemotherapy, 1988
openaire   +2 more sources

Epidemiology and Clinical Outcomes of Meningococcal Infections in Japan: A Nationwide Inpatient Database Study From 2010 to 2023. [PDF]

J Epidemiol
Kutsuna S, Ohbe H, Kimura Y, Yokoyama S, Matsui H, Fushimi K, Yasunaga H.   +6 more
europepmc   +1 more source

Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications. [PDF]

PLoS One
Carrillo Infante C, Mujeebuddin A.
europepmc   +1 more source

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland. [PDF]

Ther Adv Neurol Disord
Berthele A, Aktas O, Ayzenberg I, Claus H, Lâm TT, Löscher WN, Pröbstel AK, Prüss H, Rademacher N, Ringelstein M, Rommer P, Schara-Schmidt U, Schoser B, Weber JR, Zschüntzsch J, Meisel A, Lünemann JD.   +16 more
europepmc   +1 more source

An unusual presentation of meningococcal meningitis. [PDF]

Am J Ophthalmol Case Rep
Khan AZ, Fineide F, Utheim TP.
europepmc   +1 more source

Lumbar puncture use and antibiotic treatment in newly admitted febrile children following index cases of invasive infections. [PDF]

BMC Infect Dis
Mauritz MD, Sehlbrede M, Wager J, Aydin M.   +3 more
europepmc   +1 more source